Subchronic treatment with kynurenine and probenecid: Effects on prepulse inhibition and firing of midbrain dopamine neurons

Journal of Neural Transmission

Volumn 113, Issue 5, 2006, Pages 557-571

  Nilsson, L K ^a   Linderholm, K R ^a   Erhardt, S ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Kynurenic acid; Nicotine; Schizophrenia

Indexed keywords

KYNURENINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINE TARTRATE; PROBENECID;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG EXPOSURE; ELECTROPHYSIOLOGY; MALE; MESENCEPHALON; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

ACOUSTIC STIMULATION; ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; INHIBITION (PSYCHOLOGY); KYNURENINE; MALE; MESENCEPHALON; NEURONS; NICOTINE; PROBENECID; RATS; RATS, SPRAGUE-DAWLEY; STARTLE REACTION; STATISTICS, NONPARAMETRIC;

EID: 33646379643     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-005-0343-z     Document Type: Article

References (96)

1. A Abi-Dargham J Rodenhiser D Printz Y Zea-Ponce R Gil LS Kegeles R Weiss TB Cooper JJ Mann RL Van Heertum JM Gorman M Laruelle 2000 From the cover: increased baseline occupancy of D2 receptors by dopamine in schizophrenia Proc Natl Acad Sci USA 97 8104 8109
2. CM Adler AK Malhotra I Elman T Goldberg M Egan D Pickar A Breier 1999 Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia Am J Psychiatry 156 1646 1649
3. GW Albers WM Clark RP Atkinson K Madden JL Data MJ Whitehouse 1999 Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke Stroke 30 508 513
4. VP Bakshi M Tricklebank HC Neijt V Lehmann-Masten MA Geyer 1999 Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats J Pharmacol Exp Ther 288 643 652
5. AJ Berger S Dieudonne P Ascher 1998 Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses J Neurophysiol 80 3336 3340
6. R Bergeron TM Meyer JT Coyle RW Greene 1998 Modulation of N-methyl-D-aspartate receptor function by glycine transport Proc Natl Acad Sci USA 95 15730 15734
7. M Bertolino S Vicini E Costa 1989 Kynurenic acid inhibits the activation of kainic and N-methyl-D-aspartic acid-sensitive ionotropic receptors by a different mechanism Neuropharmacology 28 453 457
8. PJ Birch CJ Grossman AG Hayes 1988 Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor Eur J Pharmacol 154 85 87
9. LJ Bristow L Landon KL Saywell MD Tricklebank 1995 The glycine/NMDA receptor antagonist, L-701,324 reverses isolation-induced deficits in prepulse inhibition in the rat Psychopharmacology 118 230 232
10. RJ Carey 1991 Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance Brain Res 568 205 214
11. RJ Carey 1993 Motoric sensitization and levodopa accumulation after chronic levodopa treatment in an animal model of Parkinson's disease J Geriatr Psychiatry Neurol 6 152 160
12. A Carlsson M Lindqvist 1963 Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain Acta Pharmacol Toxicol 20 140 144
13. A Carlsson N Waters S Holm-Waters J Tedroff M Nilsson ML Carlsson 2001 Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence Annu Rev Pharmacol Toxicol 41 237 260
14. L Chen M Muhlhauser CR Yang 2003 Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo J Neurophysiol 89 691 703
15. JH Connick GC Heywood GJ Sills GG Thompson MJ Brodie TW Stone 1992 Nicotinylalanine increases cerebral kynurenic acid content and has anticonvulsant activity Gen Pharmacol 23 235 239
16. JT Coyle R Schwarcz 2000 Mind glue: implications of glial cell biology for psychiatry Arch Gen Psychiatry 57 90 93
17. S Cull-Candy S Brickley M Farrant 2001 NMDA receptor subunits: diversity, development and disease Curr Opin Neurobiol 11 327 335
18. L Curatolo C Caccia C Speciale L Raimondi M Cini M Marconi A Molinari R Schwarcz 1996 Modulation of extracellular kynurenic acid content by excitatory amino acids in primary cultures of rat astrocytes Adv Exp Med Biol 398 273 276
19. R Depoortere G Perrault DJ Sanger 1999 Prepulse inhibition of the startle reflex in rats: effects of compounds acting at various sites on the NMDA receptor complex Behav Pharmacol 10 51 62
20. S Erhardt G Engberg 2002 Increased phasic activity of dopaminergic neurons in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid Acta Physiol Scand 175 45 53
21. S Erhardt K Blennow C Nordin E Skogh LH Lindstrom G Engberg 2001a Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia Neurosci Lett 13 96 98
22. S Erhardt H Öberg JM Mathé G Engberg 2001b Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons Naunyn Schmiedebergs Arch Pharmacol 20 353 362
23. S Erhardt L Schwieler G Engberg 2002a Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine Synapse 43 227 237
24. S Erhardt JM Mathé G Engberg TH Svensson 2002b GABA(B) receptor mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo Naunyn Schmiedebergs Arch Pharmacol 365 173 180
25. S Erhardt L Schwieler G Engberg 2003 Kynurenic acid and schizophrenia Adv Exp Med Biol 527 155 165
26. S Erhardt L Schwieler C Emanuelsson M Geyer 2004 Endogenous kynurenic acid disrupts prepulse inhibition Biol Psychiatry 56 255 260
27. ED French 1994 Phencyclidine and the midbrain dopamine system: electrophysiology and behavior Neurotoxicol Teratol 16 355 362
28. ED French A Mura T Wang 1993 MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists Synapse 13 108 116
29. AH Ganong CW Cotman 1986 Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus J Pharmacol Exp Ther 236 293 299
30. MA Geyer NR Swerdlow RS Mansbach DL Braff 1990 Startle response models of sensorimotor gating and habituation deficits in schizophrenia Brain Res Bull 25 485 498
31. MA Geyer K Krebs-Thomson DL Braff NR Swerdlow 2001 Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Psychopharmacology 156 117 155
32. AA Grace BS Bunney 1984a The control of firing pattern in nigral dopamine neurons: single spike firing J Neurosci 4 2866 2876
33. AA Grace BS Bunney 1984b The control of firing pattern in nigral dopamine neurons: burst firing J Neurosci 4 2877 2890
34. P Grillner TH Svensson 2000 Nicotine-induced excitation of midbrain dopamine neurons in vitro involves ionotropic glutamate receptor activation Synapse 38 1 9
35. J Grotta W Clark B Coull LC Pettigrew B Mackay LB Goldstein I Meissner D Murphy L LaRue 1995 Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) inpatients with acute ischemic stroke. Results of a phase IIa randomized trial Stroke 26 602 605
36. HG Grunze DG Rainnie ME Hasselmo E Barkai EF Hearn RW McCarley RW Greene 1996 NMDA-dependent modulation of CA1 local circuit inhibition J Neurosci 16 2034 2043
37. GJ Guillemin BJ Brew 2002 Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease Redox Rep 7 199 206
38. GJ Guillemin SJ Kerr GA Smythe DG Smith V Kapoor PJ Armati J Croitoru BJ Brew 2001 Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection J Neurochem 78 842 853
39. KM Harris PA Rosenberg 1993 Localization of synapses in rat cortical cultures Neuroscience 53 495 508
40. C Hilmas EF Pereira M Alkondon A Rassoulpour R Schwarcz EX Albuquerque 2001 The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications J Neurosci 21 7463 7473
41. T Itil A Keskiner N Kiremitci JMC Holden 1967 Effects of phencyclidine in chronic schizophrenics Can Psychiatr Assoc J 12 209 212
42. DC Javitt 2004 Glutamate as a therapeutic target in psychiatric disorders Mol Psychiatry 9 984 997
43. DC Javitt SR Zukin 1991 Recent advances in the phencyclidine model of schizophrenia Am J Psychiatry 148 1301 1308
44. JD Jentsch RH Roth 1999 The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacol 20 201 225
45. M Kessler T Terramani G Lynch M Baudry 1989 A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists J Neurochem 52 1319 1328
46. JS Kim HH Kornhuber W Schmid-Burgk B Holzmuller 1980 Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia Neurosci Lett 20 379 382
47. C Kiss G Ceresoli-Borroni P Guidetti CL Zielke HR Zielke R Schwarcz 2003 Kynurenate production by cultured human astrocytes J Neural Transm 110 1 14
48. JH Krystal LP Karper JP Seibyl GK Freeman R Delaney JD Bremner GR Heninger MB Bowers DS Charney 1994 Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 51 199 214
49. Q Li DV Lewis WA Wilson 2002 NMDA-receptor antagonists disinhibit rat posterior cingulated and retrosplenial cortices: a potential mechanism of neurotoxicity J Neurosci 22 3070 3080
50. JS Lindahl J Keifer 2004 Glutamate receptor subunits are altered in forebrain and cerebellum in rats chronically exposed to the NMDA receptor antagonist phencyclidine Neuropsychopharmacology 29 2065 2073
51. ED Luby BD Cohen G Rosenbaum JS Gottlieb R Kelly 1959 Study of a new schizophrenomimetic drug - Seernyl Arch Neurol Psychiat 81 363 369
52. AK Malhotra DA Pinals CM Adler I Elman A Clifton D Pickar A Breier 1997 Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic free schizophrenics Neuropsychopharmacology 17 141 150
53. RS Mansbach MA Geyer 1989 Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat Neuropsychopharmacology 2 299 308
54. RS Mansbach MA Geyer 1991 Parametric determinants in pre-stimulus modification of acoustic startle: Interaction with ketamine Psychopharmacology 105 162 168
55. RS Mansbach MA Geyer DL Braff 1988 Dopaminergic stimulation disrupts sensorimotor gating in the rat Psychopharmacology 94 507 514
56. DS McGehee MJS Heath S Gelber P Devay LW Role 1995 Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors Science 269 1692 1696
57. MJ Millan 2005 N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives Psychopharmacology 179 30 53
58. EJ Molinari O Delbono ML Messi M Renganathan SP Arneric JP Sullivan M Gopalakrishnan 1998 Up-regulation of human alpha7 nicotinic receptors by chronic treatment with activator and antagonist ligands Eur J Pharmacol 347 131 139
59. F Moroni P Russi G Lombard M Beni V Carla 1988a Presence of kynurenic acid in the mammalian brain J Neurochem 51 177 180
60. F Moroni P Russi V Carla G Lombardi 1988b Kynurenic acid is present in the rat brain and its content increases during development and aging processes Neurosci Lett 94 145 150
61. PF Morrison GM Morishige KE Beagles MP Heyes 1999 Quinolinic acid is extruded from the brain by a probenecid-sensitive carrier system: a quantitative analysis J Neurochem 72 2135 2144
62. N Müller M Riedel C Scheppach B Brandstatter S Sokullu K Krampe M Ulmschneider RR Engel HJ Moller MJ Schwarz 2002 Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia Am J Psychiatry 159 1029 1034
63. EA Newman 2003 New roles for astrocytes: regulation of synaptic transmission Trends Neurosci 26 536 542
64. Nilsson LK, Linderholm KR, Engberg G, Jönsson EG, Paulson L, Blennow K, Lindström LH, Nordin C, Karanti A, Persson P, Erhardt S (2005) Elevated levels of kynurenic acid in the cerebrospinal fluid of schizophrenic patients. Analysis in a larger cohort. Schizophr Res (in press)
65. K Nozaki MF Beal 1992 Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats J Cereb Blood Flow Metab 12 400 407
66. S Oh YH Kim HJ Hann HL Lee HS Choi HS Kim IK Ho 2001 Modulation of the levels of NMDA receptor subunit mRNA and the bindings of [3H]MK-801 in rat brain by chronic infusion of subtoxic dose of MK-801 Neurochem Res 26 559 565
67. CG Parsons W Danysz G Quack S Hartmann B Lorenz C Wollenburg L Baran E Przegalinski W Kostowski P Krzascik B Chizh PM Headley 1997 Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization J Pharmacol Exp Ther 283 1264 1275
68. Paxinos G, Watson C (eds) (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, New York
69. R Paylor M Nguyen JN Crawley J Patrick A Beaudet A Orr-Urtreger 1998 α7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra-7 deficient mice Learn Mem 5 302 316
70. EF Pereira C Hilmas MD Santos M Alkondon A Maelicke EX Albuquerque 2002 Unconventional ligands and modulators of nicotinic receptors J Neurobiol 53 479 500
71. RC Roberts KE McCarthy F Du OP Ottersen E Okuno R Schwarcz 1995 3-Hydroxyanthranilic acid oxygenase-containing astrocytic processes surround glutamate-containing axon terminals in the rat striatum J Neurosci 15 1150 1161
72. A Santamaría C Ríos F Solís-Hernandez J Ordaz-Moreno L González-Reynoso M Altagracia J Kravzov 1996 Systemic DL-kynurenine and probenecid pretreatment attenuates quinolinicacid-induced neurotoxicity in rats Neuropharmacology 35 23 28
73. * nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area Synapse 38 375 383
74. B Schilström N Rawal M Mameli-Engvall GG Nomikos TH Svensson 2003 Dual effects of nicotine on dopamine neurons mediated by different nicotinic receptor subtypes Int J Neuropsychopharmacol 6 1 11
75. B Schilström M Mameli-Engvall N Rawal P Grillner K Jardemark TH Svensson 2004 Nitric oxide is involved in nicotine-induced burst firing of rat ventral tregmental area dopamine neurons Neuroscience 125 957 964
76. R Schwarcz A Rassoulpour HQ Wu D Medoff CA Tamminga RC Roberts 2001 Increased cortical kynurenate content in schizophrenia Biol Psychiatry 50 521 530
77. L Schwieler S Erhardt 2003 Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid Neuropsychopharmacology 28 1770 1777
78. L Schwieler G Engberg S Erhardt 2004a Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex Synapse 52 114 122
79. L Schwieler S Erhardt C Erhardt G Engberg 2005a Prostaglandin-mediated control of rat brain kynurenic acid synthesis - opposite actions by COX-1 and COX-2 isoforms J Neural Transm 112 863 872
80. Schwieler L, Erhardt S, Nilsson L, Linderholm K, Engberg G (2005b) Endogenous kynurenic acid tonically modulates firing of midbrain dopamine neurons. Int J Neuropsychopharmacol (in press)
81. KE Stevens AE Bullock AC Collins 2001 Chronic corticosterone treatment alters sensory gating in C3H mice Pharmacol Biochem Behav 69 359 366
82. TW Stone 1993 Neuropharmacology of quinolinic and kynurenic acids Pharmacol Rev 45 309 379
83. TW Stone JH Connick 1985 Quinolinic acid and other kynurenines in the central nervous system Neuroscience 15 597 617
84. TW Stone MN Perkins 1981 Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS Eur J Pharmacol 72 411 412
85. TW Stone GM Mackay CM Forrest CJ Clark LG Darlington 2003 Tryptophan metabolites and brain disorders Clin Chem Lab Med 41 852 859
86. KJ Swartz MJ During A Freese MF Beal 1990 Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors J Neurosci 10 2965 2973
87. CA Tamminga 1998 Schizophrenia and glutamatergic transmission Crit Rev Neurobiol 12 21 36
88. E Toth H Sershen A Hashim ES Vizi A Lajtha 1992 Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid Neurochem Res 17 265 271
89. WA Turski M Nakamura WP Todd BK Carpenter WO Whetsell Jr R Schwarcz 1988 Identification and quantification of kynurenic acid in human brain tissue Brain Res 454 164 169
90. WA Turski JB Gramsbergen H Traitler R Schwarcz 1989 Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine J Neurochem 52 1629 1636
91. L Vécsei J Miller U MacGarvey MF Beal 1992 Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain Brain Res Bull 28 233 238
92. RY Wang 1981 Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization Brain Res Rev 3 123 140
93. C Wang VM Showalter GR Hillman KM Johnson 1999 Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain J Neurosci Res 55 762 769
94. G Werner VB Mountcastle 1963 The variability of central neural activity in a sensory system and its implification for the central reflection of sensory events J Neurophysiol 26 958 977
95. HQ Wu P Guidetti JH Goodman M Varasi G Ceresoli-Borroni C Speciale HE Scharfman R Schwarcz 2000 Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo Neuroscience 97 243 251
96. XF Zhang XT Hu FJ White ME Wolf 1997 Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors J Pharmacol Exp Ther 281 699 706